相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reversing LRP5-Dependent Osteoporosis and SOST Deficiency-Induced Sclerosing Bone Disorders by Altering WNT Signaling Activity
Ming-Kang Chang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Dkk-1-Mediated Inhibition of Wnt Signaling in Bone Ameliorates Osteoarthritis in Mice
Thomas Funck-Brentano et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury
Martine Roudier et al.
ARTHRITIS AND RHEUMATISM (2013)
The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b
Julia Brun et al.
BONE (2013)
WNT signaling in bone homeostasis and disease: from human mutations to treatments
Roland Baron et al.
NATURE MEDICINE (2013)
To Wnt or not to Wnt: the bone and joint health dilemma
Rik J. Lories et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Osteoarthritis year 2013 in review: clinical
N. K. Arden et al.
OSTEOARTHRITIS AND CARTILAGE (2013)
Load Regulates Bone Formation and Sclerostin Expression through a TGFβ-Dependent Mechanism
Jacqueline Nguyen et al.
PLOS ONE (2013)
Osteochondral alterations in osteoarthritis
Sunita Suri et al.
BONE (2012)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J. L. Murray et al.
LANCET (2012)
Bone remodelling in osteoarthritis
David B. Burr et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration?
P. M. van der Kraan et al.
OSTEOARTHRITIS AND CARTILAGE (2012)
Targeting Bone Alleviates Osteoarthritis in Osteopenic Mice and Modulates Cartilage Catabolism
Thomas Funck-Brentano et al.
PLOS ONE (2012)
WNT-3A modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathways
Giovanna Nalesso et al.
JOURNAL OF CELL BIOLOGY (2011)
Osteoarthritis: an update with relevance for clinical practice
Johannes W. J. Bijlsma et al.
LANCET (2011)
Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis
B. Y. Chan et al.
OSTEOARTHRITIS AND CARTILAGE (2011)
The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse
S. S. Glasson et al.
OSTEOARTHRITIS AND CARTILAGE (2010)
Activation of beta-Catenin Signaling in Articular Chondrocytes Leads to Osteoarthritis-Like Phenotype in Adult beta-Catenin Conditional Activation Mice
Mei Zhu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Sclerostin in Mineralized Matrices and van Buchem Disease
R. L. van Bezooijen et al.
JOURNAL OF DENTAL RESEARCH (2009)
Inhibition of β-catenin signaling in articular chondrocytes results in articular cartilage destruction
Mei Zhu et al.
ARTHRITIS AND RHEUMATISM (2008)
Osteoprotegerin inhibits cartilage degradation through an effect on trabecular bone in murine experimental osteoarthritis
A. Kadri et al.
ARTHRITIS AND RHEUMATISM (2008)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Wnt/β-catenin signaling stimulates matrix catabolic genes and activity in articular chondrocytes:: its possible role in joint degeneration
Takahito Yuasa et al.
LABORATORY INVESTIGATION (2008)
Primary culture and phenotyping of murine chondrocytes
Marjolaine Gosset et al.
NATURE PROTOCOLS (2008)
Wnt-beta-catenin signaling in the pathogenesis of osteoarthritis
Maripat Corr
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
Osteophytes: relevance and biology
Peter M. van der Kraan et al.
OSTEOARTHRITIS AND CARTILAGE (2007)
Opposing roles of WNT-5A and WNT-11 in interleukin-1β regulation of type II collagen expression in articular chondrocytes
Je-Hwang Ryu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
RL van Bezooijen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
High bone density due to a mutation in LDL-receptor-related protein 5
LM Boyden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
YQ Gong et al.
CELL (2001)
分享论文
